Company / Operating Cash Flow per Share
Senti Biosciences Holdings, Inc. Operating Cash Flow per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$8.57
FY2025
5-year range
-$11.65 / -$0.80
FY2022-FY2025
Trend
+25.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $-0.80 to $-8.57 over the past 2 years.
Based on SEC 10-K filings.
-8.57 in FY2025.
Declined from $-0.80 to $-8.57 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 25.2% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$8.57 | +25.2% |
| FY2024 | -$11.47 | -1324.9% |
| FY2023 | -$0.80 | +93.1% |
| FY2022 | -$11.65 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026